News Sentiment

INBS sentiment intelligence

Intelligent Bio Solutions Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 2.16 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.6% over one week, -10.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.6% Price reacting lower
Trend fit Trend inactive -10.0% over four weeks
Fair value -93.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 28
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 9
TradingKey 8
Stock Titan 5
Quiver Quantitative 3
StockStory 2
GlobeNewswire 2
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 19
Analyst action 2
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
Moomoo Direct company coverage

Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News

This document appears to be a stub or placeholder from Intelligent Bio Solutions related to its stock options chain, quotes, and news. There is no substantive content provided beyond the title.

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 17:39
Source
Moomoo
Finviz Direct company coverage

INBS - Intelligent Bio Solutions Inc Revenue Breakdown

This article provides a detailed financial overview of Intelligent Bio Solutions Inc (INBS), including its market capitalization, income, sales, and various financial ratios. It also lists key performance indicators such as EPS, sales growth, insider and institutional ownership,

Tone
Negative 32/100
Event
Earnings
Published
03 Jul 2026 15:40
Source
Finviz
TradingView Direct company coverage

Enterprise value to EBIT forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS

This article provides the enterprise value to forward EBIT for Intelligent Bio Solutions Inc. (NASDAQ: INBS). It is presented on a financial data page within the TradingView platform, showing only the "Period", "Value", "Change", and "Change %" categories without populating them.

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 16:12
Source
TradingView
TradingView Direct company coverage

INBS Forecast — Price Target — Prediction for 2027

This article provides a forecast for Intelligent Bio Solutions Inc. (INBS) stock, detailing analyst price targets, historical performance, and key financial metrics. It highlights that one analyst has a price target of $12.00, while the stock has seen a significant decrease over

Tone
Neutral 50/100
Event
Analyst action
Published
27 Jun 2026 09:09
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS

This article provides financial information for Intelligent Bio Solutions Inc. (NASDAQ: INBS) on TradingView, specifically focusing on its price-to-sales forward metric. It indicates that the market is currently closed with no trades. The core content is limited to presenting the

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 02:09
Source
TradingView
TradingView Direct company coverage

Intelligent Bio Solutions Inc. Actuals & Estimates (NASDAQ:INBS)

This article provides comprehensive financial data, analyst estimates, and performance metrics for Intelligent Bio Solutions Inc. (NASDAQ:INBS). It details the company's current stock price, historical highs and lows, market capitalization, earnings, revenue, and future forecasts

Tone
Negative 20/100
Event
Earnings
Published
26 Jun 2026 21:40
Source
TradingView
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Intelligent Bio Solutions Inc (INBS), noting its current valuation score of 8.07, ranking 174 out of 388 in its industry. It highlights the company's P/E ratio of -0.19 and mentions that relevant data for P/B, P/S, and P/CF have not y

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 23:11
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Intelligent Bio Solutions Inc (INBS), noting its current price momentum score and suggesting it's suitable for range-bound swing trading as it trades between resistance at $2.50 and support at $1.94. The analysis includes various tech

Tone
Negative 29/100
Event
Market update
Published
22 Jun 2026 11:39
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Intelligent Bio Solutions Inc (INBS) stock performance, dividend history, and stock split events. It highlights that the company has not distributed any dividends over the past five years and details several merger-related stock splits with th

Tone
Neutral 50/100
Event
Deals and strategy
Published
19 Jun 2026 09:09
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Institutional Confidence

This article from TradingKey provides an overview of the institutional confidence in Intelligent Bio Solutions Inc (INBS). It details the company's stock information, including its market cap and recent price movements, and presents institutional shareholding data with significan

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 09:39
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Intelligent Bio Solutions Inc (INBS), detailing its regional revenue contributions. As of the latest update, the company has not yet disclosed relevant data for its business segments and certain financial periods. However, the existin

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 03:10
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Intelligent Bio Solutions Inc (INBS) shareholder structure, including major individual shareholders, institutional holdings, and shareholder types. It lists key individual investors like Sakiris (Spiro Kevin) and Simeonidis (Harry) al

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:10
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis

Intelligent Bio Solutions Inc (INBS) has a stable financial status with a current financial score of 6.73, ranking 223rd in the Biotechnology & Medical Research industry. The company reported a significant year-over-year revenue increase of 45.54% and a net profit increase of 12.

Tone
Positive 60/100
Event
Earnings
Published
17 Jun 2026 08:09
Source
TradingKey
TradingKey Direct company coverage

Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Intelligent Bio Solutions Inc (INBS) currently lacks an earnings forecast score, contrasting with the Biotechnology & Medical Research industry average of 8.13. Analyst forecasts set an average price target of $12.00 for INBS, with both the highest and lowest predictions at this

Tone
Positive 59/100
Event
Earnings
Published
17 Jun 2026 08:09
Source
TradingKey
The Globe and Mail Direct company coverage

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Intelligent Bio Solutions Inc. announced the initiation of a clinical Interference Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. This study, which will enroll 75 healthy adults a

Tone
Positive 73/100
Event
Market update
Published
16 Jun 2026 21:10
Source
The Globe and Mail
Stock Titan Direct company coverage

Study tests if everyday substances can skew fingerprint drug screens

Intelligent Bio Solutions (INBS) has initiated an Interference Study for its Intelligent Fingerprinting Drug Screening System to detect codeine. This study, conducted with CenExel Clinical Research, will enroll 75 healthy adults to assess how common substances affect test accurac

Tone
Positive 61/100
Event
Market update
Published
16 Jun 2026 21:10
Source
Stock Titan
TradingView Direct company coverage

Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection

Intelligent Bio Solutions (INBS) has initiated an Interference Study to support its FDA 510(k) submission for codeine detection using its Intelligent Fingerprinting Drug Screening System. The study will involve 75 healthy adults to assess the impact of common interferents, with r

Tone
Positive 66/100
Event
Market update
Published
16 Jun 2026 20:40
Source
TradingView
Quiver Quantitative Direct company coverage

Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System

Intelligent Bio Solutions Inc. has launched an Interference Study for its Intelligent Fingerprinting Drug Screening System to validate its specificity for codeine detection. This study, involving 75 healthy adults, is a crucial part of the company's FDA 510(k) submission for U.S.

Tone
Positive 63/100
Event
Market update
Published
16 Jun 2026 12:43
Source
Quiver Quantitative
TradingView Direct company coverage

Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings

This article provides an overview of Intelligent Bio Solutions Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports. It highlights key financial performance metrics such as revenue growth, gross margin improvements, and progress on FDA cle

Tone
Positive 70/100
Event
Earnings
Published
12 Jun 2026 16:09
Source
TradingView
Stocktwits Direct company coverage

INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership

Intelligent Bio Solutions Inc. (INBS) saw its stock reverse early gains, trading 2% lower after announcing the first shipment of its Intelligent Fingerprinting Drug Screening Readers, manufactured under a partnership with Syrma Johari MedTech. These devices are being deployed acr

Tone
Negative 35/100
Event
Deals and strategy
Published
06 Jun 2026 03:39
Source
Stocktwits
www.marketscreener.com Direct company coverage

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Intelligent Bio Solutions Inc. (INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company will participate in investor meetings and present on June 17th. INBS specializes in rapid, non-invasive fingerprint-based

Tone
Positive 65/100
Event
Market update
Published
04 Jun 2026 12:39
Source
www.marketscreener.com
Stock Titan Direct company coverage

Vegas microcap conference adds Intelligent Bio Solutions to lineup

Intelligent Bio Solutions (Nasdaq: INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company is scheduled to present on June 17, 2026, and will host one-on-one investor meetings throughout the event. This partic

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 12:39
Source
Stock Titan
Investing.com Direct company coverage

Intelligent Bio Solutions starts FDA study for fingerprint drug test

Intelligent Bio Solutions Inc. (NASDAQ:INBS) has commenced a multi-site study for its Intelligent Fingerprinting Drug Screening System for codeine, aiming for FDA 510(k) clearance in the U.S. The study, conducted with CenExel Clinical Research, will assess the system's accuracy w

Tone
Positive 66/100
Event
Market update
Published
02 Jun 2026 12:55
Source
Investing.com
TradingView Direct company coverage

Intelligent begins multi-site study to support FDA 510(k) for codeine screening

Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study to support its FDA 510(k) submission for its Fingerprinting Drug Screening System for codeine. The study, conducted with CenExel, will evaluate the system's accuracy with typical workplace oper

Tone
Positive 71/100
Event
Market update
Published
02 Jun 2026 12:53
Source
TradingView
The Manila Times Direct company coverage

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. This study aims to support its FDA 510(k) submission for U.S. market clearance specifically for the opiate codeine. The company expects

Tone
Positive 71/100
Event
Guidance
Published
02 Jun 2026 12:48
Source
The Manila Times